Gut Microbiota and Non-Alcoholic Fatty Liver Disease Severity in Type 2 Diabetes Patients.

Tsai, Hui-Ju; Tsai, Yi-Chun; Hung, Wei-Wen; Hung, Wei-Chun; Chang, Chen-Chia; Dai, Chia-Yen

Tsai, Hui-Ju; Tsai, Yi-Chun; Hung, Wei-Wen; Hung, Wei-Chun; Chang, Chen-Chia; Dai, Chia-Yen.

Afiliación

Tsai HJ; Department of Family Medicine, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 801, Taiwan.
Tsai YC; Department of Family Medicine, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
Hung WW; Division of General Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
Hung WC; Division of Nephrology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
Chang CC; School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
Dai CY; Cohort Research Center, Kaohsiung Medical University, Kaohsiung 807, Taiwan.

J Pers Med ; 11(3)2021 Mar 23.

Article en En | MEDLINE | ID: mdl-33807075

Palabras clave

fibroscan; gut microbiota; non-alcoholic fatty liver disease; type 2 diabetes

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: J Pers Med Año: 2021 Tipo del documento: Article País de afiliación: Taiwán

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google